Inactive Instrument

Sector Chart Nexus BioPharma, Inc. Other OTC

Equities

NEXS

US65341U1043

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
125B
108B
24.57B -
22.82B -
18.19B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW